Skip to content

Exploration and functional enrichment analysis of cirRNA-miRNA-mRNA regulatory networks related to focal cortical dysplasia

Exploration and functional enrichment analysis of cirRNA-miRNA-mRNA regulatory networks related to focal cortical dysplasia

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050352
Enrollment
Unknown
Registered
2021-08-26
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focal cortical dysplasia

Interventions

focal cortical dysplasia group vs. non focal cortical dysplasia group:Nil

Sponsors

He'nan Provincial Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 44 Years

Inclusion criteria

Inclusion criteria: 1. In the FCD group, epilepsy was diagnosed preoperatively, with unsatisfactory control of various antiepileptic drugs, FCD was confirmed by postoperative pathology, and the family members of the patients were informed and agreed to participate in the program preoperatively; 2. The control group was the patients with traumatic brain tissue that had to be removed, and the patients' family members were informed and agreed to participate in the program before surgery; 3. In the tumor group, patients were diagnosed with intracranial tumor preoperatively and glioblastoma by pathology post-operatively, and their family members were informed and agreed to participate in the program preoperatively.

Exclusion criteria

Exclusion criteria: The collected specimens do not meet the test requirements.

Design outcomes

Primary

MeasureTime frame
quality of life;

Countries

China

Contacts

Public ContactDong Yan

The Third Affiliated Hospital of Zhengzhou University

dongyanzz29@126.com+86 15037161010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026